المؤلفون: V. I. Zozina, S. N. Kondratenko, E. V. Shikh, L. M. Krasnykh, E. S. Melnikov, V. G. Kukes, В. И. Зозина, С. Н. Кондратенко, Е. В. Ших, Л. М. Красных, Е. С. Мельников, В. Г. Кукес

المصدر: Pharmacokinetics and Pharmacodynamics; № 4 (2023); 55-62 ; Фармакокинетика и Фармакодинамика; № 4 (2023); 55-62 ; 2686-8830 ; 2587-7836

مصطلحات موضوعية: этилметилгидроксипиридина малат, ubiquinol, ubiquinone, redox state, ubidecarenone, ethylmethylhydroxypyridine malate, убихинол, убихинон, редокс-статус, убидекаренон

وصف الملف: application/pdf

العلاقة: https://www.pharmacokinetica.ru/jour/article/view/393/356Test; Sifuentes-Franco S, Sánchez-Macías DC, Carrillo-Ibarra S, et al. Antioxidant and Anti-Inflammatory Effects of Coenzyme Q10 Supplementation on Infectious Diseases. Healthcare (Basel). 2022 Mar 7; 10(3):487. DOI:10.3390/healthcare10030487.; Testai L, Martelli A, Flori L, et al. Coenzyme Q10: Clinical Applications beyond Cardiovascular Diseases. Nutrients. 2021 May 17;13(5):1697. DOI:10.3390/nu13051697.; Gutierrez-Mariscal FM, Yubero-Serrano EM, Villalba JM, Lopez- Miranda J. Coenzyme Q10: From bench to clinic in aging diseases, a translational review. Crit Rev Food Sci Nutr. 2019;59(14):2240–2257. DOI:10.1080/10408398.2018.1442316.; Tang PH, Miles MV, DeGrauw A, Hershey A, Pesce A. HPLC analysis of reduced and oxidized coenzyme Q(10) in human plasma. Clin Chem. 2001 Feb;47(2):256-65.; Hargreaves IP. Coenzyme Q10 as a therapy for mitochondrial disease. Int J Biochem Cell Biol. 2014 Apr;49:105–111. DOI:10.1016/j.biocel.2014.01.020.; Yubero D, Montero R, Martín MA, et al. Secondary coenzyme Q10 deficiencies in oxidative phosphorylation (OXPHOS) and non-OXPHOS disorders. Mitochondrion. 2016 Sep;30:51–58. DOI:10.1016/j.mito.2016.06.007.; Ates O, Bilen H, Keles S, et al. Plasma coenzyme Q10 levels in type 2 diabetic patients with retinopathy. Int J Ophthalmol. 2013 Oct 18;6(5):675– 679. DOI:10.3980/j.issn.2222-3959.2013.05.24.; Shen Q, Pierce JD. Supplementation of Coenzyme Q10 among Patients with Type 2 Diabetes Mellitus. Healthcare (Basel). 2015 May 21;3(2):296–309. DOI:10.3390/healthcare3020296.; Ayer A, Macdonald P, Stocker R. CoQ Function and Role in Heart Failure and Ischemic Heart Disease. Annu Rev Nutr. 2015;35:175–213. DOI:10.1146/annurev-nutr-071714-034258.; Cocchi MN, Giberson B, Berg K, et al. Coenzyme Q10 levels are low and associated with increased mortality in post-cardiac arrest patients. Resuscitation. 2012 Aug;83(8):991–995. DOI:10.1016/j.resuscitation.2012.03.023.; Xu Y, Liu J, Han E, et al. Efficacy of coenzyme Q10 in patients with chronic kidney disease: protocol for a systematic review. BMJ Open. 2019 May 14;9(5):e029053. DOI:10.1136/bmjopen-2019-029053.; Zhao S, Wu W, Liao J, et al. Molecular mechanisms underlying the renal protective effects of coenzyme Q10 in acute kidney injury. Cell Mol Biol Lett. 2022 Jul 22;27(1):57. DOI:10.1186/s11658-022-00361-5.; Mantle D, Hargreaves I. Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview. Antioxidants (Basel). 2019 Feb 16;8(2):44. DOI:10.3390/antiox8020044.; DiNicolantonio JJ, Bhutani J, McCarty MF, O'Keefe JH. Coenzyme Q10 for the treatment of heart failure: a review of the literature. Open Heart. 2015 Oct 19;2(1):e000326. DOI:10.1136/openhrt-2015-000326.; Yamamoto Y, Yamashita S. Ubiquinol/ubiquinone ratio as a marker of oxidative stress. Methods Mol Biol. 2002;186:241–246. DOI:10.1385/1-59259-173-6:241.; Shikh E, Zozina V, Kondratenko S, et al. The particulars of certain drugs' effect on the endogenous coenzyme Q10 plasma level in patients with cardiovascular diseases. Drug Metab Pers Ther. 2020 Jun 30;35(2):/ j/dmdi.2020.35.issue-2/dmpt-2020-0106/dmpt-2020-0106.xml. DOI:10.1515/dmpt-2020-0106.; Zozina V, Melnikov E, Krasnykh L, et al. The impact of cardiovascular and bronchopulmonary diseases on Coenzyme Q10 plasma concentration. Sechenov Medical Journal. 2019;10(1):16–21. DOI:10.47093/22187332.2019.1.16-21.; Zozina VI, Melnikov ES, Goroshko OA, et al. Analytical Method Development for Coq10 Determination in Human Plasma Using HPLC-UV and HPLC/MS/MS. Current Pharmaceutical Analysis. 2019;15(7):795–807. DOI:10.2174/1573412915666190328215854.; ЕМА Guideline on bioanalytical method validation. European Medicines Agency Committee for medicinal products for human use: London. 2011. Available at: https://clck.ru/36DvaYTest Accessed May 5, 2003.; FDA Guidance for Industry: Bioanalytical method validation (draft guidance). US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evolution and Research (CDER) 2013;U.S. Government Printing Office: Washington, DC. Available at: https://clck.ru/36DvbSTest. Accessed May 5, 2003.; Бондарева И.Б., Бунятян Н.Д., Жердев В.П. и др. Методические указания: оценка биоэквивалентности лекарственных средств. 2008. Bondareva IB, Bunyatyan ND, Zherdev VP et al. Metodicheskie ukazaniya: ocenka bioekvivalentnosti lekarstvennyh sredstv. 2008. (In Russ.).; Miles MV, Horn PS, Tang PH, et al. Age-related changes in plasma coenzyme Q10 concentrations and redox state in apparently healthy children and adults. Clin Chim Acta. 2004 Sep;347(1-2):139–144. DOI:10.1016/j.cccn.2004.04.003.; Niklowitz P, Onur S, Fischer A, Laudes M, Palussen M, Menke T, Döring F. Coenzyme Q10 serum concentration and redox status in European adults: influence of age, sex, and lipoprotein concentration. J Clin Biochem Nutr. 2016 May;58(3):240–245. DOI:10.3164/jcbn.15-73.; Quinzii CM, López LC, Von-Moltke J, et al. Respiratory chain dysfunction and oxidative stress correlate with severity of primary CoQ10 deficiency. FASEB J. 2008 Jun;22(6):1874–1885. DOI:10.1096/fj.07-100149.; Ulla A, Mohamed MK, Sikder B, et al. Coenzyme Q10 prevents oxidative stress and fibrosis in isoprenaline induced cardiac remodeling in aged rats. BMC Pharmacol Toxicol. 2017 Apr 20;18(1):29. DOI:10.1186/s40360-017-0136-7.; Cirilli I, Damiani E, Dludla PV, et al. Role of Coenzyme Q10 in Health and Disease: An Update on the Last 10 Years (2010-2020). Antioxidants (Basel). 2021 Aug 23;10(8):1325. DOI:10.3390/antiox10081325.; Khan NA, Abid M, Ahmad A, Abuzinadah MF, Basheikh M, Kishore K. Cardioprotective Effect of Coenzyme Q10 on Apoptotic Myocardial Cell Death by Regulation of Bcl-2 Gene Expression. J Pharmacol Pharmacother. 2017 Jul-Sep;8(3):122–127. DOI:10.4103/jpp.JPP_47_17.; Мареев В.Ю, Минина Ю.В., Беграмбекова Ю.Л. Кудесан® (капли 3 % для приема внутрь) в лечении больных сердечной недостаточностью: эффективность и безопасность в комбинации со стандартной терапией (Кудесник). Дизайн и результаты проспективного рандомизированного двойного слепого исследования Кудесник. Сердечная Недостаточность. 2016;17:236–249. DOI:10.18087/rhfj.2016.4.2257. Mareev VYu, Minina YuV, Begrambekova YuL. Kudesan® (kapli 3% dlya priema vnutr') v lechenii bol'nyh serdechnoj nedostatochnost'yu: effektivnost' i bezopasnost' v kombinacii so standartnoj terapiej (Kudesnik). Dizajn i rezul'taty prospektivnogo randomizirovannogo dvojnogo slepogo issledovaniya Kudesnik. Serdechnaya Nedostatochnost'. 2016;17:236–249. (In Russ.). DOI:10.18087/rhfj.2016.4.2257.; Кукес В.Г., Парфенова О.К., Романов Б.К. и др. Механизм действия Этоксидола на показатели окислительного стресса при сердечной недостаточности и гипертонии. Современные технологии медицины. 2020;12(2):67–72. DOI:10.17691/stm2020.12.2.08. Kukes VG, Parfenova OK, Romanov BK. Stress Indices in Heart Failure and Hypotension. Sovrem Tekhnologii Med. 2020;12(2):67–72. (In Russ.). DOI:10.17691/stm2020.12.2.08.; Gupta S, Sodhi S, Mahajan V. Correlation of antioxidants with lipid peroxidation and lipid profile in patients suffering from coronary artery disease. Expert Opin Ther Targets. 2009 Aug;13(8):889–894. DOI:10.1517/14728220903099668.; Lee BJ, Lin YC, Huang YC, et al. The relationship between coenzyme Q10, oxidative stress, and antioxidant enzymes activities and coronary artery disease. ScientificWorldJournal. 2012;2012:792756. DOI:10.1100/2012/792756.; https://www.pharmacokinetica.ru/jour/article/view/393Test

الإتاحة: https://doi.org/10.37489/2587-7836-2023-4-55-62Test
https://doi.org/10.3390/healthcare10030487Test
https://doi.org/10.3390/nu13051697Test
https://doi.org/10.1080/10408398.2018.1442316Test
https://doi.org/10.1016/j.biocel.2014.01.020Test
https://doi.org/10.1016/j.mito.2016.06.007Test
https://doi.org/10.3980/j.issn.2222-3959.2013.05.24Test
https://doi.org/10.3390/healthcare3020296Test
https://doi.org/10.1146/annurev-nutr-071714-034258Test
https://doi.org/10.1016/j.resuscitation.2012.03.023Test

المؤلفون: H Jahanpour, M Chamani, AR Seidavi, AA Sadeghi, M Aminafschar

المصدر: Poultry Science Journal, Vol 8, Iss 2, Pp 145-162 (2020)

مصطلحات موضوعية: ascites, growth, ubidecarenone, broiler chicken, feed restriction, Animal culture, SF1-1100

وصف الملف: electronic resource

العلاقة: http://psj.gau.ac.ir/article_5198_c3a1923269b8943e8236ba07ba0a3bca.pdfTest; https://doaj.org/toc/2345-6604Test; https://doaj.org/toc/2345-6566Test

الوصول الحر: https://doaj.org/article/1e4aa4aaed1e490bb1ae2a9eb6799a62Test

المؤلفون: Anandakumar, K.^{1, 1}, Sangeetha, V. P.¹, Sindhuja, V.¹, Iswarya, S. Sree¹, Ramesh, J.¹, Arun, N T.¹, Raja, M.²

المصدر: Research Journal of Pharmacy and Technology 13(5):2233-2237. 2020

المؤلفون: Karunakaran, Anandakumar, Elampulakkadu, Anjana, Jayaprakash, Ramesh, Raju, Senthilkumar, Lakshmiganesh, Meka Dharshini

المصدر: MPI (Media Pharmaceutica Indonesiana); Vol. 3 No. 4 (2021): DECEMBER; 197-207 ; 2527-9017 ; 2527-6298 ; 10.24123/mpi.v3i4

مصطلحات موضوعية: formulation, HPTLC, ICH guidelines, methanol, ubidecarenone

وصف الملف: application/pdf

العلاقة: https://journal.ubaya.ac.id/index.php/MPI/article/view/4734/3522Test; https://journal.ubaya.ac.id/index.php/MPI/article/view/4734Test

الإتاحة: https://doi.org/10.24123/mpi.v3i4.4734Test
https://doi.org/10.24123/mpi.v3i4Test
https://journal.ubaya.ac.id/index.php/MPI/article/view/4734Test

المؤلفون: Müderris, Togay, Sevil, Ergun, Yar Sağlam, A.S., Babademez, M.A.

مصطلحات موضوعية: Antioxidants, Evoked Potentials, Auditory, Brain Stem, Oxidative Stress, Presbycusis, cyclooxygenase 2, immunoglobulin enhancer binding protein, interleukin 10, messenger RNA, protein Bak, protein Bax, protein bcl 2, tumor necrosis factor, ubidecarenone, animal experiment, animal model, animal tissue, apoptosis, Article, auditory threshold, brain stem response, controlled study, down regulation, evoked brain stem auditory response, forced vital capacity, gene expression, hearing impairment, lipid peroxidation, mouse

العلاقة: Turk Geriatri Dergisi; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://doi.org/10.31086/tjgeri.2021.220Test; https://hdl.handle.net/20.500.14034/357Test; 24; 235; 243; 2-s2.0-85116143769

الإتاحة: https://doi.org/20.500.14034/357Test
https://doi.org/10.31086/tjgeri.2021.220Test
https://hdl.handle.net/20.500.14034/357Test

المؤلفون: Mohammad B.I., Hadi N.R., Singh R.B., Shastun S., Sharmanov T., Tazhibayev S., Gumarova L.

المصدر: World Heart Journal

مصطلحات موضوعية: angiotensin receptor, carnitine, enalapril, eplerenone, hydralazine plus isosorbide dinitrate, membrane metalloendopeptidase, omega 3 fatty acid, sacubitril plus valsartan, ubidecarenone, valsartan, Article, atrial fibrillation, cardiovascular mortality, cardiovascular risk, clinical feature, diabetes mellitus, drug efficacy, drug mechanism, food and drug administration, heart ejection fraction, heart failure, heart left ventricle ejection fraction, heart left ventricle wall, heart volume, hospitalization, human, kidney function, morbidity, New York Heart Association class, nutritional deficiency

العلاقة: https://openrepository.ru/article?id=255417Test

الإتاحة: https://openrepository.ru/article?id=255417Test

المؤلفون: Jianmin Wang, Huiyun Wang, Qiang Xia

المصدر: International Journal of Molecular Sciences; Volume 19; Issue 7; Pages: 1865

مصطلحات موضوعية: ubidecarenone, nanostructured lipid carrier, antioxidation, reactive oxygen species, percutaneous penetration

جغرافية الموضوع: agris

وصف الملف: application/pdf

العلاقة: Materials Science; https://dx.doi.org/10.3390/ijms19071865Test

الإتاحة: https://doi.org/10.3390/ijms19071865Test

المؤلفون: I. V. Leontyeva, E. A. Nikolaeva, И. В. Леонтьева, Е. А. Николаева

المصدر: Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics); Том 61, № 3 (2016); 22-30 ; Российский вестник перинатологии и педиатрии; Том 61, № 3 (2016); 22-30 ; 2500-2228 ; 1027-4065 ; 10.21508/1027-4065-2017-7-4

مصطلحات موضوعية: левокарнитин, cardiomyopathy, mitochondrial disease, Kearns–Sayre syndrome, MELAS syndrome, MERRF syndrome, NARP syndrome, Barth syndrome, Leigh syndrome, ubidecarenone, succinates, cytochrome C, levocarnitine, кардиомиопатия, митохондриальное заболевание, синдромы Кернса–Сейра, MELAS, MERRF, NARP, Барта, Ли, убидекаренон, сукцинаты, цитохром С

وصف الملف: application/pdf

العلاقة: https://www.ped-perinatology.ru/jour/article/view/321/356Test; Wilkinson J.D., Landy D.C., Colan S.D. et al. The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years. Heart Fail Clin 2010; 6: 401–441.; Byers S.L., Ficicioglu C. Infant with cardiomyopathy: When to suspect inborn errors of metabolism? World J Cardiol 2014; 6: 11: 1149–1155.; Cox G.F. Diagnostic approaches to pediatric cardiomyopathy of metabolic genetic etiologies and their relation to therapy. Prog Pediatr Cardiol 2007; 24: 15–25.; Elliott P., Andersson B., Arbustini E. et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008; 29: 270–276.; Meyers D.E., Basha H.I., Koenig M.K. Mitochondrial cardiomyopathy: pathophysiology, diagnosis, and management. Tex Heart Inst J 2013; 40: 385–394.; Berardo A., Musumeci O., Toscano A. Cardiological manifestations of mitochondrial respiratory chain disorders. Acta Myologica 2011; XXX: 9–15.; Holmgren D., Wahlander H., Eriksson B.O. et al. Cardiomyopathy in children with mitochondrial disease: clinical course and cardiological findings. Eur Heart J 2003; 4: 280–288.; Kompare M., Rizzo W.B. Mitochondrial fatty-acid oxidation disorders. Semin Pediatr Neurol 2008; 15: 140–149.; Noji H., Yoshida M. The rotary machine of the cell, ATP synthase. J Biol Chem 2001; 276: 1665–1668.; Niizuma K., Endo H., Chan P.H. Oxidative stress and mitochondrial dysfunction as determinants of ischemic neuronal death and survival. J Neurochem 2009; 109: 133–138.; Mehrazin M., Shanske S., Kaufmann P. et al. Longitudinal changes of mtDNA A3243G mutation load and level of functioning in MELAS. Am J Med Genet 2009; 149: 584–587.; Zeviani M., Moraes C.T., DiMauro S. et al. Deletions of mitochondrial DNA in Kearns–Sayre syndrome. Neurology 1998; 51: 1525–1533.; Hudson G., Deschauer M., Taylor R.W. et al. POLG1, C10ORF2, and ANT1 mutations are uncommon in sporadic progressive external ophthalmoplegia with multiple mitochondrial DNA deletions. Neurology 2006; 66: 1439–1441.; López-Gallardo E., López-Pérez M.J., Montoya J. et al. CPEO and KSS differ in the percentage and location of the mtDNA deletion. Mitochondrion 2009; 9: 314–317.; Van Goethem G., Martin J.J., Van Broeckhoven C. Progressive external ophthalmoplegia and multiple mitochondrial DNA deletions. Acta Neurol Belg 2002; 102: 39–42.; Papa S., Petruzzella V., Scacco S. et al. Pathogenetic mechanisms in hereditary dysfunctions of complex I of the respiratory chain in neurological diseases. Biochim Biophys Acta 2009; 1787: 502–517.; Monnot S., Chabrol B., Cano A. et al. Cytochrome c oxydasedeficient Leigh syndrome with homozygous mutation in SURF1 gene. Arch Pediatr 2005; 12: 568–571.; Mobley B.C., Enns G.M., Wong L.J. et al. A novel homozygous SCO2 mutation, p.G193S, causing fatal infantile cardioencephalomyopathy. Clin Neuropathol 2009; 28: 143–149.; Jordens E.Z., Palmieri L., Huizing M. et al. Adenine nucleotide translocator 1 deficiency associated with Sengers syndrome. Ann Neurol 2002; 52: 95–99.; Palmieri L., Alberio S., Pisano I. et al. Complete loss-of-function of the heart/muscle-specific adenine nucleotide translocator is associated with mitochondrial myopathy and cardiomyopathy. Hum Mol Genet 2005; 14: 3079–3088.; Joost K., Rodenburg R., Piirsoo A. et al. A novel mutation in the SCO2 gene in a neonate with early-onset cardioencephalomyopathy. Pediatr Neurol 2010; 42: 227–230.; Zeviani M. The expanding spectrum of nuclear gene mutations in mitochondrial disorders. Semin Cell Dev Biol 2001; 12: 407–416.; Николаева Е.А. Диагностика и профилактика ядерно-кодируемых митохондриальных заболеваний у детей. Рос вестн перинатол и педиатр 2014; 59: 2: 19–28. (Nikolaeva E.А. Diagnostics and prevention of nuclear coded mitochondrial diseases at children. Ros vestn perinatol i pediatr 2014; 59: 2: 19–28.); Colan S.D. Hypertrophic cardiomyopathy in childhood. Heart Fail Clin 2010; 6: 433–444.; Houtkooper R.H., Turkenburg M., Poll-The B.T. et al. The enigmaticrole of tafazzin in cardiolipin metabolism. Biochim Biophys Acta 2009; 1788: 2003.; Леонтьева И.В., Николаева Е.А. Поражение сердца при синдроме Барта. Рос вестн перинатол и педиатр 2016; 1: 26–32. (Leont’eva I.V., Nikolaeva E.А. Cardiac damage in Barth syndrome. Ros vestn perinatol i pediatr 2016; 1: 26–32.); Pandolfo M., Pastore A.The pathogenesis ofFriedreich ataxia and the structure and function of frataxin. J Neurol 2009; 256: 9–17.; Delatycki M.B. Evaluating the progression of Friedreich ataxia and its treatment. J Neurol 2009; 256: Suppl 1: 36–41.; Yaplito-Lee J., Weintraub R., Jamsen K. et al. Cardiac manifestations in oxidative phosphorylation disorders of childhood. J Pediatr 2007; 150: 407–411.; Di Leo R., Musumeci O., de Gregorio C. et al. Evidence of cardiovascular autonomic impairment in mitochondrial disorders. J Neurol 2007; 254: 1498–1503.; Scaglia F., Towbin J.A., Craigen W.J. et al. Clinical spectrum, morbidity,and mortality in 113 pediatric patients with mitochondrial disease. Pediatrics 2004; 114: 925–931.; Wabbels B., Ali N., Kunz W.S. et al. Chronic progressive external ophthalmoplegia and Kearns–Sayre syndrome: interdisciplinary diagnosis and therapy. Ophthalmology 2008; 105: 550–556.; Young T.J., Shah A.K., Lee M.H., Hayes D.L. Kearns–Sayre syndrome: a case report and review of cardiovascular complications. Pacing Clin Electrophysiol 2005; 28: 454–457.; Леонтьева И.В., Николаева Е.А., Сухоруков В.С. Варианты поражения сердечно-сосудистой системы при синдроме Кернса–Сейра. Рос вестн перинатол и педиатр 1999; 6: 26–32. (Leont’eva I.V., Nikolaeva E.А., Suchorukov V.S. Variants of cardiovascular lesion in Kearns–Sayre syndrome. Рос вестн перинатол и педиатр 1999; 6: 26–32.); Charles R., Holt S., Kay J.M. et al. Myocardial ultrastructure and the development of atrioventricular block in Kearns–Sayre syndrome. Circulation 1981; 63: 214–219.; Fromenty B., Carrozzo R., Shanske S., Schon E.A. High proportions of mtDNA duplications in patients with Kearns–Sayre syndrome occur in the heart. Am J Med Genet 1997; 71: 4: 443–452.; Kakura H., Tachibana Y., Nakamura K. et al. Mitochondrial encephalomyopathy (Kearns–Sayre syndrome) with complete atrioventricular block: a case report. Jpn Circ J 1998; 62: 8: 623–625.; Lewy P., Leroy G., Haiat R. et al. Kearns–Sayre syndrome. A rare indication for prophylactic cardiac pacing. Arch Mal Coeur Vaiss 1997; 90: 1: 93–97.; Subbiah R.N., Kuchar D., Baron D. Torsades de pointes in a patient with Kearns–Sayre syndrome: a fortunate finding. Pacing Clin Electrophysiol 2007; 30: 137–139.; Consalvo D., Villegas F., Villa A. Severe cardiac failure in Kearns–Sayre syndrome. Medicina (B Aires) 1997; 57: 1: 67–71.; Akaike M., Kawai H., Yokoi K. Cardiac dysfunction in patients with chronic progressive external ophthalmoplegia. Clin Cardiol 1997; 20: 3: 239–243.; Kabunga P., Lau A.K., Phan K. et al. Systematic review of cardiac electrical disease in Kearns–Sayre syndrome and mitochondrial cytopathy. Int J Cardiol 2015; 181: 303–310.; Hübner G., Gokel J.M., Pongratz D. et al. Fatal mitochondrial cardiomyopathy in Kearns–Sayre syndrome. Virchows Arch A Pathol Anat Histopathol 1986; 408: 6: 611–621.; Krauch G., Wilichowski E., Schmidt K.G. et al. Pearson marrowpancreas syndrome with worsening cardiac function caused by pleiotropic rearrangement of mitochondrial DNA. Am J Med Genet 2002; 110: 57–61.; Sproule D.M., Kaufmann P. Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype,and therapeutic management of MELAS syndrome. Ann N Y Acad Sci 2008; 1142: 133–158.; Kolb S.J., Costello F., Lee A.G. et.al. Distinguishing ischemic stroke from the stroke-like lesions of MELAS using apparent diffusion coefficient mapping. J Neurol Sci 2003; 216: 11–15.; GotoY.,Nonaka I.,Horai S.A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990; 348: 651–653.; Finsterer J. Genetic, pathogenetic, and phenotypic implications of the mitochondrial A3243G tRNALeu (UUR) mutation. Acta Neurol Scand 2007; 116: 1–14.; Finsterer J. MELAS in the heart. Int J Cardiol 2009; 137: 65–66.; Anan R., Nakagawa M., Miyata M. et al. Cardiac involvement in mitochondrial diseases. A study on 17 patients with documented mitochondrial DNA defects. Circulation 1995; 91: 955–961.; Sproule D.M., Kaufmann P., Engelstad K. et al. Wolff–Parkinson–White syndrome in patients with MELAS. Arch Neurol 2007; 64: 1625–1627.; Sato W., Tanaka M., Sugyama S. et al. Cardiomyopathy and angiopathy in patients with mithochondrial myopathy encephalopathy lactic acidosis and stroke like episodes. Amer Heart J 1994; 128: 4: 733–741.; Леонтьева И.В. Кардиомиопатии при первичной митохондриальной патологии. Лечащий врач 2002; 7-8: 58-66. (Leont’eva I.V. Cardiomyopathies at primary mitochondrial pathology. Lechashhij vrach 2002; 7-8: 58–66.); Molnar M.J., Perenyi J., Siska E. et al. The typical MERRF (A8344G) mutation of the mitochondrial DNA associated with depressive mood disorders. J Neurol 2009; 256: 264–265.; Ozava T. Mitochondrial cardiomyopathy. Herz 1994; 19: 2: 105–118.; Wahbi K., Larue S., Jardel C. et al. Cardiac involvement is frequentin patients with the m.8344A>G mutation of mitochondrial DNA. Neurology 2010; 74: 674–677.; Сухоруков В.С. Очерки митохондриальной патологии. М: Медпрактика–М, 2011; 288. (Sukhorukov V.S. Mitochondrial pathology outlines. Moscow: Medpraktika 2011; 288.); López-Gallardo E., Solano A., Herrero-Martín M.D. et al. NARP syndrome in a patient harbouring an insertion in the MT-ATP6 gene that results in a truncated protein. J Med Genet 2009; 46: 64–67.; Bugiani M., Invernizzi F., Alberio S. et al. Clinical and molecular findings in children with complex I deficiency. Biochim Biophys Acta 2004; 1659: 136–147.; Piao Y.S., Tang G.C., Yang H. et al. Clinico-neuropathological study of a Chinese case of familiar adult Leigh syndrome. Neuropathol 2006; 26: 218–221.; Levitas A., Muhammad E., Harel G. et al. Familial neonatal isolated cardiomyopathy caused by a mutation in the flavoprotein subunit of succinate dehydrogenase. Eur J Hum Genet 2010; 18: 1160–1165.; Николаева Е.А., Яблонская М.И., Харабадзе М.Н. и др. Эффективность комплексной терапии при разных формах митохондриальных заболеваний у детей. Рос вестн перинатол и педиатр 2009; 6: 26-30. (Nikolaeva E.А., Yablonskaya M.I., Kharabadze M.N. et al. Efficiency of complex therapy at different forms of mitochondrial diseases at children. Ros vestn perinatol i pediatr 2009; 6: 26–30.); Arakawa K., Kudo T., Ikawa M. et al. Abnormal myocardial energyproduction state in mitochondrial cardiomyopathy and acute response to L-arginine infusion: C-11 acetate kinetics revealed by positron emission tomography. Circ J 2010; 74: 2702.; Finsterer J., Stöllberger C., Gelpi E. Successful heart failure therapy in mitochondrial disorder with noncompaction cardiomyopathy Int J Cardiovasc Imaging 2006; 22: 393–398.; Fosslien E. Mitochondrial medicine–cardiomyopathy caused by defective oxidative phosphorylation. Ann Clin Lab Sci 2003; 33: 371–395.; Santorelli F.M., Gagliardi M.G., Dionisi-Vici C. et al. Hypertrophic cardiomyopathy and mtDNA depletion. Successful treatment with heart transplantation. Neuromuscul Disord 2002; 12: 56–59.; https://www.ped-perinatology.ru/jour/article/view/321Test

الإتاحة: https://doi.org/10.21508/1027-4065-2016-61-3-22-3010.21508/1027-4065-2017-7-4Test
https://www.ped-perinatology.ru/jour/article/view/321Test

المؤلفون: Ak, H., GülÅŸen, I., Çölçimen, N., Alp, H.H., Akyol, M.E., Demir, Ä°smail, Atalay, T.

مصطلحات موضوعية: Neuron density, ubiquinone, animal experiment, Key words Malondialdehyde, Stereology, Thymoquinone, Traumatic brain injury, glutathione peroxidase, malonaldehyde, superoxide dismutase, ubidecarenone, antioxidant, benzoquinone derivative, neuroprotective agent, animal model, animal tissue, Article, biochemical analysis, brain tissue, cell density, controlled study, dentate hilus, DNA isolation, enzyme analysis, female, heart perfusion, hippocampal CA1 region, hippocampal CA2 region, hippocampal CA3 region, hippocampus

العلاقة: World Neurosurgery; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://hdl.handle.net/11499/9702Test; https://doi.org/10.1016/j.wneu.2015.09.052Test; 86; 243; 249; 2-s2.0-84959488780; WOS:000369625300057

الإتاحة: https://doi.org/10.1016/j.wneu.2015.09.052Test
https://hdl.handle.net/11499/9702Test

المؤلفون: Tu, G.-W, Song, J.-Q, Ting, S.K.S, Ju, M.-J, He, H.-Y, Dong, J.-H, Luo, Z

المساهمون: DUKE-NUS MEDICAL SCHOOL

المصدر: Unpaywall 20201031

مصطلحات موضوعية: caspofungin, cotrimoxazole, Cytomegalovirus antibody, fentanyl, ganciclovir, immunoglobulin M antibody, methylprednisolone, morphine, moxifloxacin, mycophenolate mofetil, prednisolone, propofol, rocuronium, tacrolimus, ubidecarenone, virus DNA, vitamin B group, acute disease, acute graft rejection, adult, areflexia, Article, artificial ventilation, case report, computer assisted tomography, critical illness, critical illness polyneuropathy and myopathy, cytomegalovirus infection, daily life activity, disease severity

العلاقة: Tu, G.-W, Song, J.-Q, Ting, S.K.S, Ju, M.-J, He, H.-Y, Dong, J.-H, Luo, Z (2015). Acute quadriplegia caused by necrotizing myopathy in a renal transplant recipient with severe pneumonia: Acute onset and complete recovery. European Journal of Medical Research 20 (1) : 11. ScholarBank@NUS Repository. https://doi.org/10.1186/s40001-015-0087-7Test; 9492321; https://scholarbank.nus.edu.sg/handle/10635/180344Test

الإتاحة: https://doi.org/10.1186/s40001-015-0087-7Test
https://scholarbank.nus.edu.sg/handle/10635/180344Test